AbbVie Inc. is 19.3x more valuable than INSMED Inc by market capitalization ($397.44 B vs $20.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INSM | ABBV |
|---|---|---|
| Market cap | $20.58 B | $397.44 B |
| US-listed rank | #609 | #28 |
| Revenue (latest FY) | $606.42M | $61.16B |
| Net income (latest FY) | -$1.28B | $4.23B |
| Net margin | -210.5% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 1,776 | 1,008 |
AbbVie Inc. is 19.3x more valuable than INSMED Inc by market capitalization ($397.44 B vs $20.58 B).
In their latest fiscal years, INSMED Inc reported $606.42M in revenue while AbbVie Inc. reported $61.16B.
Full pages: INSMED Inc and AbbVie Inc., or browse the full rankings.